Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
BIOLOGICAL ADHESION |
42 |
1032 |
2.174e-32 |
1.012e-28 |
2 |
IMMUNE SYSTEM PROCESS |
46 |
1984 |
2.742e-25 |
6.379e-22 |
3 |
LOCOMOTION |
36 |
1114 |
8.014e-24 |
1.243e-20 |
4 |
CELL ACTIVATION |
27 |
568 |
7.56e-22 |
8.794e-19 |
5 |
REGULATION OF CELL PROLIFERATION |
37 |
1496 |
1.486e-20 |
1.383e-17 |
6 |
REGULATION OF IMMUNE SYSTEM PROCESS |
36 |
1403 |
1.831e-20 |
1.42e-17 |
7 |
SINGLE ORGANISM CELL ADHESION |
24 |
459 |
2.398e-20 |
1.594e-17 |
8 |
CELL MOTILITY |
29 |
835 |
9.502e-20 |
4.512e-17 |
9 |
LOCALIZATION OF CELL |
29 |
835 |
9.502e-20 |
4.512e-17 |
10 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
34 |
1275 |
9.696e-20 |
4.512e-17 |
11 |
LEUKOCYTE MIGRATION |
19 |
259 |
6.661e-19 |
2.818e-16 |
12 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
28 |
867 |
3.245e-18 |
1.258e-15 |
13 |
LYMPHOCYTE ACTIVATION |
20 |
342 |
6.229e-18 |
2.23e-15 |
14 |
CELL CELL ADHESION |
24 |
608 |
1.554e-17 |
5.163e-15 |
15 |
POSITIVE REGULATION OF CELL ACTIVATION |
19 |
311 |
2.065e-17 |
6.406e-15 |
16 |
REGULATION OF CELL ACTIVATION |
22 |
484 |
2.3e-17 |
6.688e-15 |
17 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
37 |
1929 |
7.116e-17 |
1.948e-14 |
18 |
LEUKOCYTE ACTIVATION |
20 |
414 |
2.532e-16 |
6.545e-14 |
19 |
LEUKOCYTE CELL CELL ADHESION |
17 |
255 |
2.819e-16 |
6.902e-14 |
20 |
REGULATION OF IMMUNE RESPONSE |
26 |
858 |
3.229e-16 |
7.512e-14 |
21 |
REGULATION OF CELL ADHESION |
23 |
629 |
4.372e-16 |
9.687e-14 |
22 |
POSITIVE REGULATION OF CELL ADHESION |
19 |
376 |
6.889e-16 |
1.457e-13 |
23 |
REGULATION OF CELL CELL ADHESION |
19 |
380 |
8.362e-16 |
1.692e-13 |
24 |
BLOOD VESSEL MORPHOGENESIS |
18 |
364 |
6.406e-15 |
1.242e-12 |
25 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
30 |
1395 |
9.591e-15 |
1.785e-12 |
26 |
POSITIVE REGULATION OF CELL PROLIFERATION |
24 |
814 |
1.062e-14 |
1.901e-12 |
27 |
POSITIVE REGULATION OF CELL CELL ADHESION |
15 |
243 |
5.822e-14 |
1.003e-11 |
28 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
16 |
307 |
1.078e-13 |
1.792e-11 |
29 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
31 |
1672 |
1.633e-13 |
2.62e-11 |
30 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
26 |
1142 |
2.697e-13 |
4.184e-11 |
31 |
REGULATION OF CELL DEATH |
29 |
1472 |
2.901e-13 |
4.355e-11 |
32 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
22 |
771 |
3.322e-13 |
4.831e-11 |
33 |
VASCULATURE DEVELOPMENT |
18 |
469 |
4.889e-13 |
6.894e-11 |
34 |
ANGIOGENESIS |
15 |
293 |
8.877e-13 |
1.215e-10 |
35 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
10 |
82 |
1.283e-12 |
1.706e-10 |
36 |
DEFENSE RESPONSE |
26 |
1231 |
1.504e-12 |
1.899e-10 |
37 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
15 |
304 |
1.51e-12 |
1.899e-10 |
38 |
IMMUNE RESPONSE |
24 |
1100 |
6.958e-12 |
8.52e-10 |
39 |
RESPONSE TO WOUNDING |
18 |
563 |
1.035e-11 |
1.235e-09 |
40 |
POSITIVE REGULATION OF LOCOMOTION |
16 |
420 |
1.267e-11 |
1.474e-09 |
41 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
22 |
957 |
2.351e-11 |
2.668e-09 |
42 |
LYMPHOCYTE COSTIMULATION |
9 |
78 |
3.023e-11 |
3.349e-09 |
43 |
WOUND HEALING |
16 |
470 |
6.749e-11 |
7.303e-09 |
44 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
17 |
563 |
1.025e-10 |
1.084e-08 |
45 |
ACTIVATION OF IMMUNE RESPONSE |
15 |
427 |
1.847e-10 |
1.91e-08 |
46 |
CELL DEVELOPMENT |
25 |
1426 |
2.487e-10 |
2.515e-08 |
47 |
PEPTIDYL TYROSINE MODIFICATION |
11 |
186 |
2.639e-10 |
2.613e-08 |
48 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
19 |
788 |
3.166e-10 |
3.006e-08 |
49 |
CIRCULATORY SYSTEM DEVELOPMENT |
19 |
788 |
3.166e-10 |
3.006e-08 |
50 |
TAXIS |
15 |
464 |
5.825e-10 |
5.421e-08 |
51 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
21 |
1036 |
7.343e-10 |
6.571e-08 |
52 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
21 |
1036 |
7.343e-10 |
6.571e-08 |
53 |
POSITIVE REGULATION OF CELL COMMUNICATION |
25 |
1532 |
1.111e-09 |
9.569e-08 |
54 |
IMMUNE EFFECTOR PROCESS |
15 |
486 |
1.099e-09 |
9.569e-08 |
55 |
CELL CHEMOTAXIS |
10 |
162 |
1.192e-09 |
9.982e-08 |
56 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
17 |
662 |
1.223e-09 |
9.982e-08 |
57 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
17 |
662 |
1.223e-09 |
9.982e-08 |
58 |
CELL SUBSTRATE ADHESION |
10 |
164 |
1.343e-09 |
1.078e-07 |
59 |
NEGATIVE REGULATION OF CELL DEATH |
19 |
872 |
1.708e-09 |
1.347e-07 |
60 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
8 |
87 |
2.532e-09 |
1.785e-07 |
61 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
8 |
87 |
2.532e-09 |
1.785e-07 |
62 |
VIRAL ENTRY INTO HOST CELL |
8 |
87 |
2.532e-09 |
1.785e-07 |
63 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
8 |
87 |
2.532e-09 |
1.785e-07 |
64 |
MOVEMENT IN HOST ENVIRONMENT |
8 |
87 |
2.532e-09 |
1.785e-07 |
65 |
ENTRY INTO HOST |
8 |
87 |
2.532e-09 |
1.785e-07 |
66 |
ENTRY INTO HOST CELL |
8 |
87 |
2.532e-09 |
1.785e-07 |
67 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
25 |
1618 |
3.413e-09 |
2.37e-07 |
68 |
REGULATION OF CELL DIFFERENTIATION |
24 |
1492 |
3.516e-09 |
2.371e-07 |
69 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
24 |
1492 |
3.516e-09 |
2.371e-07 |
70 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
20 |
1021 |
3.651e-09 |
2.427e-07 |
71 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
19 |
926 |
4.576e-09 |
2.999e-07 |
72 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
18 |
823 |
4.665e-09 |
3.015e-07 |
73 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
25 |
1656 |
5.474e-09 |
3.489e-07 |
74 |
PROTEIN AUTOPHOSPHORYLATION |
10 |
192 |
6.177e-09 |
3.884e-07 |
75 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
12 |
323 |
7.742e-09 |
4.803e-07 |
76 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
25 |
1710 |
1.047e-08 |
6.409e-07 |
77 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
13 |
408 |
1.093e-08 |
6.602e-07 |
78 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
18 |
876 |
1.229e-08 |
7.33e-07 |
79 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
14 |
498 |
1.371e-08 |
8.077e-07 |
80 |
LYMPHOCYTE DIFFERENTIATION |
10 |
209 |
1.392e-08 |
8.094e-07 |
81 |
RECEPTOR CLUSTERING |
6 |
41 |
1.581e-08 |
9.084e-07 |
82 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
16 |
689 |
1.664e-08 |
9.44e-07 |
83 |
ADAPTIVE IMMUNE RESPONSE |
11 |
288 |
2.582e-08 |
1.447e-06 |
84 |
INNATE IMMUNE RESPONSE |
15 |
619 |
2.833e-08 |
1.551e-06 |
85 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
6 |
45 |
2.827e-08 |
1.551e-06 |
86 |
REGULATION OF AXONOGENESIS |
9 |
168 |
2.911e-08 |
1.575e-06 |
87 |
LEUKOCYTE DIFFERENTIATION |
11 |
292 |
2.973e-08 |
1.59e-06 |
88 |
CELL MATRIX ADHESION |
8 |
119 |
3.058e-08 |
1.617e-06 |
89 |
INOSITOL LIPID MEDIATED SIGNALING |
8 |
124 |
4.222e-08 |
2.207e-06 |
90 |
REGULATION OF CELL PROJECTION ORGANIZATION |
14 |
558 |
5.666e-08 |
2.929e-06 |
91 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
13 |
472 |
6.057e-08 |
3.097e-06 |
92 |
INTERACTION WITH HOST |
8 |
134 |
7.732e-08 |
3.869e-06 |
93 |
HETEROTYPIC CELL CELL ADHESION |
5 |
27 |
7.7e-08 |
3.869e-06 |
94 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
8 |
135 |
8.192e-08 |
4.012e-06 |
95 |
REGULATION OF NEURON DEATH |
10 |
252 |
8.147e-08 |
4.012e-06 |
96 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
8 |
136 |
8.676e-08 |
4.205e-06 |
97 |
REGULATION OF NEURON APOPTOTIC PROCESS |
9 |
192 |
9.197e-08 |
4.411e-06 |
98 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
9 |
193 |
9.615e-08 |
4.565e-06 |
99 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
8 |
138 |
9.716e-08 |
4.567e-06 |
100 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
9 |
195 |
1.05e-07 |
4.886e-06 |
101 |
REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS |
5 |
29 |
1.126e-07 |
5.185e-06 |
102 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
19 |
1135 |
1.179e-07 |
5.378e-06 |
103 |
PLATELET ACTIVATION |
8 |
142 |
1.212e-07 |
5.424e-06 |
104 |
TISSUE DEVELOPMENT |
22 |
1518 |
1.203e-07 |
5.424e-06 |
105 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
12 |
424 |
1.531e-07 |
6.786e-06 |
106 |
LIPID PHOSPHORYLATION |
7 |
99 |
1.649e-07 |
7.237e-06 |
107 |
REGULATION OF LEUKOCYTE PROLIFERATION |
9 |
206 |
1.676e-07 |
7.29e-06 |
108 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
8 |
156 |
2.502e-07 |
1.078e-05 |
109 |
INFLAMMATORY RESPONSE |
12 |
454 |
3.186e-07 |
1.36e-05 |
110 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
15 |
750 |
3.41e-07 |
1.443e-05 |
111 |
REGULATION OF CELL MORPHOGENESIS |
13 |
552 |
3.661e-07 |
1.535e-05 |
112 |
REGULATION OF NEURON DIFFERENTIATION |
13 |
554 |
3.815e-07 |
1.585e-05 |
113 |
REGULATION OF MAPK CASCADE |
14 |
660 |
4.381e-07 |
1.804e-05 |
114 |
NEGATIVE REGULATION OF NEURON DEATH |
8 |
171 |
5.044e-07 |
2.059e-05 |
115 |
REGULATION OF CELL SIZE |
8 |
172 |
5.273e-07 |
2.102e-05 |
116 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
5 |
39 |
5.284e-07 |
2.102e-05 |
117 |
CELLULAR CHEMICAL HOMEOSTASIS |
13 |
570 |
5.264e-07 |
2.102e-05 |
118 |
POSITIVE REGULATION OF GROWTH |
9 |
238 |
5.667e-07 |
2.235e-05 |
119 |
POSITIVE REGULATION OF CHEMOTAXIS |
7 |
120 |
6.149e-07 |
2.404e-05 |
120 |
CELLULAR COMPONENT MORPHOGENESIS |
16 |
900 |
6.342e-07 |
2.459e-05 |
121 |
IMMUNE SYSTEM DEVELOPMENT |
13 |
582 |
6.655e-07 |
2.559e-05 |
122 |
RESPONSE TO EXTERNAL STIMULUS |
23 |
1821 |
6.754e-07 |
2.576e-05 |
123 |
LOCALIZATION WITHIN MEMBRANE |
7 |
122 |
6.879e-07 |
2.602e-05 |
124 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
7 |
123 |
7.27e-07 |
2.728e-05 |
125 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
18 |
1152 |
7.424e-07 |
2.749e-05 |
126 |
REGULATION OF CHEMOTAXIS |
8 |
180 |
7.443e-07 |
2.749e-05 |
127 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
23 |
1848 |
8.74e-07 |
3.202e-05 |
128 |
CELL JUNCTION ORGANIZATION |
8 |
185 |
9.155e-07 |
3.328e-05 |
129 |
LEUKOCYTE MEDIATED IMMUNITY |
8 |
189 |
1.076e-06 |
3.88e-05 |
130 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
12 |
513 |
1.157e-06 |
4.142e-05 |
131 |
NEGATIVE REGULATION OF LOCOMOTION |
9 |
263 |
1.301e-06 |
4.622e-05 |
132 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
10 |
343 |
1.383e-06 |
4.874e-05 |
133 |
GLYCEROLIPID METABOLIC PROCESS |
10 |
356 |
1.931e-06 |
6.756e-05 |
134 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
16 |
983 |
2.015e-06 |
6.957e-05 |
135 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
13 |
643 |
2.018e-06 |
6.957e-05 |
136 |
VESICLE MEDIATED TRANSPORT |
18 |
1239 |
2.108e-06 |
7.212e-05 |
137 |
REGULATION OF TRANSPORT |
22 |
1804 |
2.277e-06 |
7.732e-05 |
138 |
T CELL RECEPTOR SIGNALING PATHWAY |
7 |
146 |
2.301e-06 |
7.759e-05 |
139 |
REGULATION OF T CELL PROLIFERATION |
7 |
147 |
2.408e-06 |
8.062e-05 |
140 |
CELL RECOGNITION |
7 |
148 |
2.52e-06 |
8.374e-05 |
141 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
6 |
95 |
2.563e-06 |
8.459e-05 |
142 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
5 |
54 |
2.766e-06 |
9.064e-05 |
143 |
REGULATION OF DEVELOPMENTAL GROWTH |
9 |
289 |
2.825e-06 |
9.192e-05 |
144 |
VIRAL LIFE CYCLE |
9 |
290 |
2.906e-06 |
9.325e-05 |
145 |
NEUROGENESIS |
19 |
1402 |
2.898e-06 |
9.325e-05 |
146 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
6 |
98 |
3.075e-06 |
9.799e-05 |
147 |
CELLULAR EXTRAVASATION |
4 |
25 |
3.109e-06 |
9.841e-05 |
148 |
POSITIVE REGULATION OF MAPK CASCADE |
11 |
470 |
3.347e-06 |
0.0001052 |
149 |
CELLULAR HOMEOSTASIS |
13 |
676 |
3.494e-06 |
0.0001091 |
150 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
9 |
297 |
3.53e-06 |
0.0001095 |
151 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
7 |
156 |
3.574e-06 |
0.0001101 |
152 |
REGULATION OF EXTENT OF CELL GROWTH |
6 |
101 |
3.666e-06 |
0.0001122 |
153 |
ION HOMEOSTASIS |
12 |
576 |
3.833e-06 |
0.0001158 |
154 |
REGULATED EXOCYTOSIS |
8 |
224 |
3.821e-06 |
0.0001158 |
155 |
INTRACELLULAR SIGNAL TRANSDUCTION |
20 |
1572 |
3.927e-06 |
0.0001179 |
156 |
NEURON DEVELOPMENT |
13 |
687 |
4.166e-06 |
0.0001242 |
157 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
8 |
232 |
4.95e-06 |
0.0001467 |
158 |
HEMOSTASIS |
9 |
311 |
5.131e-06 |
0.0001511 |
159 |
MORPHOGENESIS OF AN EPITHELIUM |
10 |
400 |
5.433e-06 |
0.000159 |
160 |
REGULATION OF HEMOPOIESIS |
9 |
314 |
5.545e-06 |
0.0001602 |
161 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
5 |
62 |
5.517e-06 |
0.0001602 |
162 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
7 |
167 |
5.606e-06 |
0.000161 |
163 |
REGULATION OF RESPONSE TO STRESS |
19 |
1468 |
5.666e-06 |
0.0001617 |
164 |
REGULATION OF ERK1 AND ERK2 CASCADE |
8 |
238 |
5.971e-06 |
0.0001694 |
165 |
HOMEOSTATIC PROCESS |
18 |
1337 |
6.127e-06 |
0.0001728 |
166 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
4 |
30 |
6.631e-06 |
0.0001859 |
167 |
REGULATION OF BODY FLUID LEVELS |
11 |
506 |
6.752e-06 |
0.0001881 |
168 |
REGULATION OF CELL DEVELOPMENT |
14 |
836 |
6.967e-06 |
0.000193 |
169 |
ENDOCYTOSIS |
11 |
509 |
7.139e-06 |
0.0001966 |
170 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
6 |
114 |
7.394e-06 |
0.0002024 |
171 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
21 |
1791 |
7.625e-06 |
0.0002075 |
172 |
POSITIVE REGULATION OF AXONOGENESIS |
5 |
69 |
9.369e-06 |
0.0002535 |
173 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
337 |
9.787e-06 |
0.0002617 |
174 |
REGULATION OF CELLULAR COMPONENT SIZE |
9 |
337 |
9.787e-06 |
0.0002617 |
175 |
TISSUE MORPHOGENESIS |
11 |
533 |
1.1e-05 |
0.0002926 |
176 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
14 |
872 |
1.123e-05 |
0.0002969 |
177 |
EPITHELIAL CELL DEVELOPMENT |
7 |
186 |
1.135e-05 |
0.0002983 |
178 |
CHEMICAL HOMEOSTASIS |
14 |
874 |
1.152e-05 |
0.0003012 |
179 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
10 |
437 |
1.176e-05 |
0.0003057 |
180 |
CELL DEATH |
15 |
1001 |
1.191e-05 |
0.0003079 |
181 |
NEURON PROJECTION DEVELOPMENT |
11 |
545 |
1.354e-05 |
0.0003482 |
182 |
POSITIVE REGULATION OF AXON EXTENSION |
4 |
36 |
1.399e-05 |
0.0003577 |
183 |
CELL JUNCTION ASSEMBLY |
6 |
129 |
1.502e-05 |
0.0003819 |
184 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
6 |
131 |
1.64e-05 |
0.0004146 |
185 |
PHOSPHOLIPID METABOLIC PROCESS |
9 |
364 |
1.806e-05 |
0.0004542 |
186 |
NEGATIVE T CELL SELECTION |
3 |
13 |
1.844e-05 |
0.0004614 |
187 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
7 |
203 |
1.999e-05 |
0.0004973 |
188 |
ENDODERMAL CELL DIFFERENTIATION |
4 |
40 |
2.144e-05 |
0.0005305 |
189 |
REGULATION OF MULTI ORGANISM PROCESS |
10 |
470 |
2.2e-05 |
0.0005417 |
190 |
REGULATION OF B CELL MEDIATED IMMUNITY |
4 |
41 |
2.368e-05 |
0.0005769 |
191 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
4 |
41 |
2.368e-05 |
0.0005769 |
192 |
LIPID MODIFICATION |
7 |
210 |
2.485e-05 |
0.0005991 |
193 |
POSITIVE REGULATION OF TRANSPORT |
14 |
936 |
2.474e-05 |
0.0005991 |
194 |
POSITIVE REGULATION OF KINASE ACTIVITY |
10 |
482 |
2.728e-05 |
0.0006461 |
195 |
EPITHELIUM DEVELOPMENT |
14 |
945 |
2.749e-05 |
0.0006461 |
196 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
7 |
213 |
2.721e-05 |
0.0006461 |
197 |
PROTEIN PHOSPHORYLATION |
14 |
944 |
2.717e-05 |
0.0006461 |
198 |
POSITIVE REGULATION OF B CELL ACTIVATION |
5 |
86 |
2.749e-05 |
0.0006461 |
199 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
8 |
296 |
2.89e-05 |
0.0006758 |
200 |
SYNAPSE ORGANIZATION |
6 |
145 |
2.914e-05 |
0.0006779 |
201 |
UROGENITAL SYSTEM DEVELOPMENT |
8 |
299 |
3.105e-05 |
0.0007189 |
202 |
LYMPHOCYTE MEDIATED IMMUNITY |
6 |
147 |
3.148e-05 |
0.000725 |
203 |
POSITIVE REGULATION OF CELL GROWTH |
6 |
148 |
3.27e-05 |
0.0007473 |
204 |
RESPONSE TO CYTOKINE |
12 |
714 |
3.278e-05 |
0.0007473 |
205 |
PHOSPHORYLATION |
16 |
1228 |
3.292e-05 |
0.0007473 |
206 |
CALCIUM MEDIATED SIGNALING |
5 |
90 |
3.426e-05 |
0.0007663 |
207 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
18 |
1518 |
3.42e-05 |
0.0007663 |
208 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
8 |
303 |
3.413e-05 |
0.0007663 |
209 |
PEPTIDYL AMINO ACID MODIFICATION |
13 |
841 |
3.561e-05 |
0.000789 |
210 |
ORGAN MORPHOGENESIS |
13 |
841 |
3.561e-05 |
0.000789 |
211 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
8 |
306 |
3.66e-05 |
0.0008071 |
212 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
17 |
1381 |
3.688e-05 |
0.0008095 |
213 |
NEURON PROJECTION MORPHOGENESIS |
9 |
402 |
3.931e-05 |
0.0008586 |
214 |
EXOCYTOSIS |
8 |
310 |
4.012e-05 |
0.0008724 |
215 |
AMEBOIDAL TYPE CELL MIGRATION |
6 |
154 |
4.087e-05 |
0.0008842 |
216 |
RESPONSE TO OXYGEN LEVELS |
8 |
311 |
4.105e-05 |
0.0008842 |
217 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
7 |
232 |
4.689e-05 |
0.001005 |
218 |
REGULATION OF RESPONSE TO WOUNDING |
9 |
413 |
4.844e-05 |
0.001029 |
219 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
4 |
49 |
4.832e-05 |
0.001029 |
220 |
REGULATION OF MAP KINASE ACTIVITY |
8 |
319 |
4.91e-05 |
0.001038 |
221 |
SECOND MESSENGER MEDIATED SIGNALING |
6 |
160 |
5.06e-05 |
0.001065 |
222 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
3 |
18 |
5.185e-05 |
0.001087 |
223 |
ENDODERM FORMATION |
4 |
50 |
5.236e-05 |
0.001093 |
224 |
NEURON DIFFERENTIATION |
13 |
874 |
5.289e-05 |
0.001099 |
225 |
REGULATION OF RESPONSE TO BIOTIC STIMULUS |
7 |
237 |
5.366e-05 |
0.001105 |
226 |
TUBE MORPHOGENESIS |
8 |
323 |
5.359e-05 |
0.001105 |
227 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
6 |
162 |
5.422e-05 |
0.001111 |
228 |
ARTERY MORPHOGENESIS |
4 |
51 |
5.664e-05 |
0.001156 |
229 |
REGULATION OF DEFENSE RESPONSE |
12 |
759 |
5.918e-05 |
0.001202 |
230 |
THYMIC T CELL SELECTION |
3 |
19 |
6.139e-05 |
0.001237 |
231 |
POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION |
3 |
19 |
6.139e-05 |
0.001237 |
232 |
REGULATION OF CALCIUM ION IMPORT |
5 |
103 |
6.545e-05 |
0.001313 |
233 |
B CELL RECEPTOR SIGNALING PATHWAY |
4 |
54 |
7.101e-05 |
0.001418 |
234 |
REGULATION OF KINASE ACTIVITY |
12 |
776 |
7.314e-05 |
0.001448 |
235 |
CELL PROJECTION ORGANIZATION |
13 |
902 |
7.289e-05 |
0.001448 |
236 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
5 |
106 |
7.505e-05 |
0.001478 |
237 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
13 |
905 |
7.538e-05 |
0.001478 |
238 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
6 |
172 |
7.561e-05 |
0.001478 |
239 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
5 |
107 |
7.848e-05 |
0.001521 |
240 |
PLATELET DEGRANULATION |
5 |
107 |
7.848e-05 |
0.001521 |
241 |
GLIOGENESIS |
6 |
175 |
8.319e-05 |
0.001606 |
242 |
TUBE DEVELOPMENT |
10 |
552 |
8.502e-05 |
0.001635 |
243 |
SYSTEM PROCESS |
19 |
1785 |
8.637e-05 |
0.001654 |
244 |
ENDOTHELIAL CELL MIGRATION |
4 |
57 |
8.787e-05 |
0.001676 |
245 |
REGULATION OF HOMEOSTATIC PROCESS |
9 |
447 |
8.884e-05 |
0.001687 |
246 |
NEURON MIGRATION |
5 |
110 |
8.948e-05 |
0.001693 |
247 |
CELL PROLIFERATION |
11 |
672 |
9.097e-05 |
0.001714 |
248 |
NEPHRON DEVELOPMENT |
5 |
115 |
0.0001104 |
0.002072 |
249 |
REGULATION OF ALPHA BETA T CELL PROLIFERATION |
3 |
23 |
0.0001109 |
0.002072 |
250 |
FOREBRAIN CELL MIGRATION |
4 |
62 |
0.0001222 |
0.002274 |
251 |
CIRCULATORY SYSTEM PROCESS |
8 |
366 |
0.0001277 |
0.002368 |
252 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
9 |
470 |
0.0001299 |
0.002398 |
253 |
REGULATION OF DEFENSE RESPONSE TO VIRUS |
6 |
190 |
0.0001307 |
0.002403 |
254 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
9 |
472 |
0.0001341 |
0.002456 |
255 |
REGULATION OF B CELL ACTIVATION |
5 |
121 |
0.0001403 |
0.002561 |
256 |
REGULATION OF ION TRANSPORT |
10 |
592 |
0.0001508 |
0.002741 |
257 |
T CELL DIFFERENTIATION |
5 |
123 |
0.0001516 |
0.002744 |
258 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
5 |
124 |
0.0001574 |
0.002839 |
259 |
KIDNEY EPITHELIUM DEVELOPMENT |
5 |
125 |
0.0001635 |
0.002936 |
260 |
REGULATION OF WOUND HEALING |
5 |
126 |
0.0001697 |
0.003036 |
261 |
REGULATION OF ION HOMEOSTASIS |
6 |
201 |
0.0001775 |
0.003165 |
262 |
POSITIVE REGULATION OF HEART GROWTH |
3 |
27 |
0.000181 |
0.003214 |
263 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
10 |
606 |
0.0001822 |
0.003223 |
264 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
289 |
0.0001844 |
0.00325 |
265 |
SENSORY ORGAN DEVELOPMENT |
9 |
493 |
0.0001857 |
0.003261 |
266 |
EPITHELIAL CELL DIFFERENTIATION |
9 |
495 |
0.0001914 |
0.003348 |
267 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
6 |
204 |
0.0001924 |
0.003352 |
268 |
NEURON PROJECTION GUIDANCE |
6 |
205 |
0.0001975 |
0.003429 |
269 |
REGULATION OF CELL GROWTH |
8 |
391 |
0.0002006 |
0.003469 |
270 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
5 |
131 |
0.0002035 |
0.003481 |
271 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
5 |
131 |
0.0002035 |
0.003481 |
272 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
3 |
28 |
0.0002021 |
0.003481 |
273 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
10 |
616 |
0.0002079 |
0.003522 |
274 |
ENDODERM DEVELOPMENT |
4 |
71 |
0.0002069 |
0.003522 |
275 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
6 |
207 |
0.0002082 |
0.003522 |
276 |
B CELL ACTIVATION |
5 |
132 |
0.0002108 |
0.003541 |
277 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
5 |
132 |
0.0002108 |
0.003541 |
278 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
5 |
133 |
0.0002183 |
0.003655 |
279 |
REGULATION OF CALCIUM ION TRANSPORT |
6 |
209 |
0.0002193 |
0.003657 |
280 |
GLIAL CELL DIFFERENTIATION |
5 |
136 |
0.0002422 |
0.004025 |
281 |
ARTERY DEVELOPMENT |
4 |
75 |
0.0002557 |
0.004234 |
282 |
CELL PART MORPHOGENESIS |
10 |
633 |
0.0002585 |
0.00425 |
283 |
REGULATION OF GROWTH |
10 |
633 |
0.0002585 |
0.00425 |
284 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
5 |
139 |
0.000268 |
0.004375 |
285 |
REGULATION OF CELL SHAPE |
5 |
139 |
0.000268 |
0.004375 |
286 |
GLIAL CELL DEVELOPMENT |
4 |
76 |
0.000269 |
0.004377 |
287 |
REGULATION OF PLATELET ACTIVATION |
3 |
31 |
0.0002748 |
0.004456 |
288 |
PATTERNING OF BLOOD VESSELS |
3 |
32 |
0.0003024 |
0.004868 |
289 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
3 |
32 |
0.0003024 |
0.004868 |
290 |
CALCIUM ION TRANSPORT |
6 |
223 |
0.0003106 |
0.004983 |
291 |
DENDRITE DEVELOPMENT |
4 |
79 |
0.0003122 |
0.004991 |
292 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
5 |
144 |
0.0003155 |
0.005027 |
293 |
TELENCEPHALON DEVELOPMENT |
6 |
228 |
0.0003496 |
0.005552 |
294 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
8 |
426 |
0.000357 |
0.00565 |
295 |
KIDNEY MORPHOGENESIS |
4 |
82 |
0.00036 |
0.005679 |
296 |
REGULATION OF CYTOKINE SECRETION |
5 |
149 |
0.0003692 |
0.005803 |
297 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
6 |
232 |
0.0003835 |
0.005988 |
298 |
EYE DEVELOPMENT |
7 |
326 |
0.0003828 |
0.005988 |
299 |
REGULATION OF VASCULATURE DEVELOPMENT |
6 |
233 |
0.0003924 |
0.006106 |
300 |
TISSUE MIGRATION |
4 |
84 |
0.0003947 |
0.006122 |
301 |
POSITIVE REGULATION OF ION TRANSPORT |
6 |
236 |
0.0004199 |
0.006491 |
302 |
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS |
5 |
154 |
0.0004295 |
0.006563 |
303 |
NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
3 |
36 |
0.0004302 |
0.006563 |
304 |
T CELL SELECTION |
3 |
36 |
0.0004302 |
0.006563 |
305 |
POSITIVE CHEMOTAXIS |
3 |
36 |
0.0004302 |
0.006563 |
306 |
REGULATION OF TRANSFERASE ACTIVITY |
12 |
946 |
0.0004566 |
0.006944 |
307 |
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE |
3 |
37 |
0.0004668 |
0.007074 |
308 |
REGULATION OF COAGULATION |
4 |
88 |
0.0004711 |
0.007118 |
309 |
REGULATION OF CYTOKINE PRODUCTION |
9 |
563 |
0.0004913 |
0.007398 |
310 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
3 |
38 |
0.0005053 |
0.007559 |
311 |
POSITIVE REGULATION OF ORGAN GROWTH |
3 |
38 |
0.0005053 |
0.007559 |
312 |
MESONEPHROS DEVELOPMENT |
4 |
90 |
0.0005131 |
0.007652 |
313 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
6 |
246 |
0.0005228 |
0.007772 |
314 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
8 |
452 |
0.0005284 |
0.007831 |
315 |
ENSHEATHMENT OF NEURONS |
4 |
91 |
0.000535 |
0.007878 |
316 |
AXON ENSHEATHMENT |
4 |
91 |
0.000535 |
0.007878 |
317 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
3 |
39 |
0.0005458 |
0.007911 |
318 |
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
3 |
39 |
0.0005458 |
0.007911 |
319 |
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
3 |
39 |
0.0005458 |
0.007911 |
320 |
PLATELET AGGREGATION |
3 |
39 |
0.0005458 |
0.007911 |
321 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
5 |
162 |
0.0005411 |
0.007911 |
322 |
POSITIVE REGULATION OF HEMOPOIESIS |
5 |
163 |
0.0005564 |
0.008016 |
323 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
5 |
163 |
0.0005564 |
0.008016 |
324 |
REGULATION OF SECRETION |
10 |
699 |
0.0005641 |
0.008101 |
325 |
NEPHRON EPITHELIUM DEVELOPMENT |
4 |
93 |
0.0005808 |
0.008316 |
326 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
5 |
166 |
0.0006044 |
0.008627 |
327 |
HEAD DEVELOPMENT |
10 |
709 |
0.0006297 |
0.00896 |
328 |
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
3 |
41 |
0.0006328 |
0.008977 |
329 |
REGULATION OF CELLULAR LOCALIZATION |
14 |
1277 |
0.0006421 |
0.009081 |
330 |
REGULATION OF INNATE IMMUNE RESPONSE |
7 |
357 |
0.000657 |
0.009208 |
331 |
FOREBRAIN DEVELOPMENT |
7 |
357 |
0.000657 |
0.009208 |
332 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
4 |
96 |
0.0006547 |
0.009208 |
333 |
SECRETION |
9 |
588 |
0.0006707 |
0.009372 |
334 |
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL |
3 |
42 |
0.0006795 |
0.009382 |
335 |
DENDRITE MORPHOGENESIS |
3 |
42 |
0.0006795 |
0.009382 |
336 |
REGULATION OF HEART GROWTH |
3 |
42 |
0.0006795 |
0.009382 |
337 |
CALCIUM ION IMPORT INTO CYTOSOL |
3 |
42 |
0.0006795 |
0.009382 |
338 |
MYELOID LEUKOCYTE ACTIVATION |
4 |
98 |
0.0007076 |
0.00974 |